Holles Natalie C.
Insider CIK 1580111 · HPTX SVP, Corp & Business Dev · AURA See Remarks, Director · ALLK Director · LONA Director · BOLD Senior Vice President, COO · RUBY Director · DAWN Director · THRD CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-06-23 | 2026-06-24 | 2,333 | — | $0 | 2,333 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2026-05-19 | 2026-05-19 | 2,169,103 | — | $0 | 2,169,103 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2026-05-19 | 2026-05-19 | 600,118 | — | $0 | 600,118 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2026-05-19 | 2026-05-19 | 553,844 | — | $0 | 1,153,962 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 56,000 | — | $0 | 56,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 22,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 15,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 28,700 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 40,300 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 40,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer | 2026-04-23 | 2026-04-23 | 57,310 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 32,335 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 28,700 | — | $0 | 28,700 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 28,700 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 40,300 | — | $0 | 40,300 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 40,300 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 40,000 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other deriv | 2025-08-11 | 2025-08-14 | 50,000 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other deriv | 2025-08-11 | 2025-08-14 | 998,854 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other | 2025-08-11 | 2025-08-14 | 1,218,836 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-05-23 | 2024-05-28 | 32,335 | — | $0 | 32,335 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | M Exercise deriv | 2024-05-09 | 2024-05-10 | 20,222 | — | $0 | 433,854 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | S Sale | 2024-05-09 | 2024-05-10 | 20,222 | $12.18 | $246.3K | 1,218,836 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | M Exercise | 2024-05-09 | 2024-05-10 | 20,222 | $4.20 | $84.9K | 1,239,058 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 13,558 | — | $0 | 454,076 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 13,558 | $4.20 | $56.9K | 1,232,394 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 13,558 | $12.19 | $165.3K | 1,218,836 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2024-01-05 | 2024-01-05 | 396,000 | — | $0 | 396,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2024-01-05 | 2024-01-09 | 396,000 | — | $0 | 396,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-06-22 | 2023-06-26 | 37,500 | — | $0 | 37,500 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 360,000 | — | $0 | 360,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 467,634 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 467,634 | — | $0 | 467,634 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 205,000 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 205,000 | — | $0 | 205,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2022-10-25 | 2022-10-27 | 205,000 | — | $0 | 205,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-06-21 | 2022-06-23 | 28,700 | — | $0 | 28,700 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2021-05-25 | 2021-10-14 | 7,700 | — | $0 | 7,700 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 50,105 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 40,883 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 93,109 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 25,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 548 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 110,703 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 104,439 | $60.00 | $6.27M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 5,715 | — | $0 | 548 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 74,117 | — | $0 | 40,883 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 6,891 | — | $0 | 93,109 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 14,895 | — | $0 | 50,105 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 45,726 | — | $0 | 110,703 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 8,681 | $59.37 | $515.4K | 46,023 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 45,726 | $2.76 | $126.2K | 91,749 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 5,715 | $9.50 | $54.3K | 97,464 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 6,891 | $27.39 | $188.7K | 178,472 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 14,895 | $24.74 | $368.5K | 193,367 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 88,928 | $59.37 | $5.28M | 104,439 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 74,117 | $15.26 | $1.13M | 171,581 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-05 | 2019-12-09 | 505 | $59.21 | $29.9K | 54,704 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-09-05 | 2019-09-09 | 505 | $31.02 | $15.7K | 55,209 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-06-05 | 2019-06-07 | 1,009 | $37.31 | $37.6K | 55,714 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-03-29 | 2019-04-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 23,333 | — | $0 | 56,723 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-01-24 | 2019-01-25 | 8,300 | — | $0 | 156,429 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-01-24 | 2019-01-25 | 8,300 | $2.76 | $22.9K | 33,390 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-06-01 | 2018-06-04 | 5,090 | — | $0 | 164,729 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-06-01 | 2018-06-04 | 5,090 | $2.76 | $14.0K | 25,090 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-05-07 | 2018-05-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-11-16 | 2017-11-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2017-05-31 | 2017-06-01 | 20,000 | — | $0 | 169,819 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2017-05-31 | 2017-06-01 | 20,000 | $2.76 | $55.2K | 20,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-01-25 | 2017-01-27 | 115,000 | — | $0 | 115,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 24,000 | $46.00 | $1.10M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 63,000 | $46.00 | $2.90M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 21,000 | $46.00 | $966.0K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 29,000 | $46.00 | $1.33M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-08 | 702 | $46.00 | $32.3K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-08 | 17,750 | $46.00 | $816.5K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2015-02-09 | 2015-02-10 | 24,000 | — | $0 | 24,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2015-02-09 | 2015-02-10 | 14,000 | — | $0 | 18,452 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | F Tax w/h | 2015-01-02 | 2015-01-05 | 548 | $24.28 | $13.3K | 4,452 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-03-11 | 2014-03-13 | 29,000 | — | $0 | 29,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-03-11 | 2014-03-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-08-16 | 2013-08-19 | 21,000 | — | $0 | 21,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-07-01 | 2013-07-02 | 63,000 | — | $0 | 63,000 | SEC↗ |